A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer
NCT01784107 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2016-02-10
Summary
Phase 1 : To evaluate MTD(Maximal tolerated dose)and DLT(Dose limiting Toxicity) of Belotecan and Ifosfamide.
Phase 2 : To analyse efficacy and toxicity of Belotecan and Ifosfamide.
Conditions
Interventions
- DRUG
-
Belotecan and Ifosfamide
Sponsors & Collaborators
-
Gachon University Gil Medical Center
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-07-31
- Primary Completion
- 2018-07-31
Countries
- South Korea
Study Locations
More Related Trials
-
Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
NCT00004186 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Irinotecan Liposome Injection as Second-line Regimen in Patients With Small Cell Lung Cancer (SCLC)
NCT04727853 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction
NCT06951841 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer
NCT01497873 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer
NCT00349492 ·Status: COMPLETED ·Phase: PHASE3
-
Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC
NCT06258642 ·Status: RECRUITING ·Phase: NA
-
Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer
NCT01876446 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer
NCT01079481 ·Status: COMPLETED ·Phase: PHASE1
-
Belotecan and Cisplatin in Treating Patients With Previously Untreated, Extensive-Stage Small Cell Lung Cancer
NCT00754858 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Different Doses of Irinotecan and Cisplatin for First-line Extensive-stage Small-cell Lung Cancer Treatment
NCT02171325 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Extensive Stage Small Cell Lung Cancer
NCT05924841 ·Status: RECRUITING ·Phase: PHASE2
-
HTMC0435 and Temozolomide in Treating Patients With Small Cell Lung Cancer
NCT05728619 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung Carcinoma
NCT00435578 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer
NCT01770795 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer
NCT00005972 ·Status: COMPLETED ·Phase: PHASE2
-
Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment
NCT01707329 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC)
NCT00431015 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase II Study of Ivonescimab Combined with Cadonilimab and Chemotherapy in Extensive-stage Small Cell Lung Cancer
NCT06620796 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient
NCT00826644 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With Chemotherapy
NCT01022671 ·Status: COMPLETED ·Phase: PHASE2
-
Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer
NCT06467786 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Investigate the Efficacy and Safety of Ivonescimab Combined With Irinotecan Liposome as Second-line Regimen for ES-SCLC
NCT06478043 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer
NCT02323737 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Biomarkers of the Second-line Treatment of Adebelizumab Combined With Irinotecan Liposome in Advanced Small Cell Lung Cancer
NCT07004712 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
NCT00030433 ·Status: COMPLETED ·Phase: PHASE2